Cormedix Inc (CRMD)
5.52
+0.26
(+5.04%)
USD |
NASDAQ |
May 01, 16:00
5.515
0.00 (0.00%)
After-Hours: 20:00
Cormedix Free Cash Flow: -38.74M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -38.74M |
| September 30, 2023 | -33.98M |
| June 30, 2023 | -31.34M |
| March 31, 2023 | -28.24M |
| December 31, 2022 | -24.58M |
| September 30, 2022 | -24.79M |
| June 30, 2022 | -25.00M |
| March 31, 2022 | -22.63M |
| December 31, 2021 | -22.58M |
| September 30, 2021 | -22.09M |
| June 30, 2021 | -23.15M |
| March 31, 2021 | -20.81M |
| December 31, 2020 | -22.08M |
| September 30, 2020 | -19.96M |
| June 30, 2020 | -16.60M |
| March 31, 2020 | -15.68M |
| December 31, 2019 | -15.09M |
| September 30, 2019 | -18.39M |
| June 30, 2019 | -19.55M |
| March 31, 2019 | -24.04M |
| December 31, 2018 | -23.75M |
| September 30, 2018 | -23.95M |
| June 30, 2018 | -25.65M |
| March 31, 2018 | -29.07M |
| December 31, 2017 | -28.74M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.84M |
| June 30, 2017 | -27.62M |
| March 31, 2017 | -23.63M |
| December 31, 2016 | -22.32M |
| September 30, 2016 | -19.46M |
| June 30, 2016 | -15.80M |
| March 31, 2016 | -15.63M |
| December 31, 2015 | -12.54M |
| September 30, 2015 | -10.48M |
| June 30, 2015 | -9.352M |
| March 31, 2015 | -7.278M |
| December 31, 2014 | -6.346M |
| September 30, 2014 | -5.696M |
| June 30, 2014 | -5.396M |
| March 31, 2014 | -4.430M |
| December 31, 2013 | -3.618M |
| September 30, 2013 | -3.224M |
| June 30, 2013 | -2.377M |
| March 31, 2013 | -2.764M |
| December 31, 2012 | -2.276M |
| September 30, 2012 | -2.653M |
| June 30, 2012 | -3.829M |
| March 31, 2012 | -4.709M |
| December 31, 2011 | -6.298M |
| September 30, 2011 | -6.632M |
Free Cash Flow Range, Past 5 Years
-38.74M
Minimum
Dec 2023
-15.09M
Maximum
Dec 2019
-23.44M
Average
-22.58M
Median
Dec 2021
Free Cash Flow Benchmarks
| BioXcel Therapeutics Inc | -155.03M |
| Assertio Holdings Inc | 48.98M |
| Verastem Inc | -86.46M |
| Ocular Therapeutix Inc | -76.32M |
| PAVmed Inc | -52.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.75M |
| Cash from Investing (Quarterly) | 0.5978M |
| Cash from Financing (Quarterly) | 0.4677M |
| Free Cash Flow Per Share (Quarterly) | -0.1921 |
| Free Cash Flow Yield | -13.80% |